HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...
HALIFAX, NS / ACCESSWIRE / August 13, 2024 / Today, MedMira Inc. (MIR:CA) (MedMira) announces it will conduct full clinical trials for its unique Multiplo ® Complete Syphilis (TP/nTP) Antibody Test ...
HALIFAX, NOVA SCOTIA / ACCESS Newswire / December 30, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2025.Corporate updateIn Q1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback